Clinical Trial Update: Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study [Phase 4]

View source ↗

Summary

Phase 4 ROTDIP study compares raltegravir against darunavir/cobicistat in immunosuppressed HIV patients; the current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Raltegravir (raltegravir)
• darunavir/cobicistat (darunavir/cobicistat)

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN